Navigation Links
DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook'
Date:10/11/2007

ty.

Our purpose [in the Interim Report], Dr. Orbach continues, is to give our citizens, legislators, and stakeholder communities a relatively digestible summary of where our Facilities Outlook stands today and a flavor for the continual careful effort of analysis, evaluation, and internal and external review that goes into our facilities planning and decision-making.

The new Interim Report provides a summary update on the status of the original 28 facilities and features three charts. One lists the 28 facilities as of the original November 2003 publication, including their R&D, conceptual design, engineering design, construction, and operation status at that time. The other two charts show the updated list of facilities and their projected status, respectively, by the conclusion of the 2007 fiscal year, which ended September 30, 2007, and by the conclusion of the 2008 fiscal year, ending September 30, 2008.

The write-ups about each of the 28 facilities include an update on their status since the Facilities Outlook and a section about their scientific purpose and significance and their prospective societal and other benefits. In cases where Department decisions about facilities have changed, a summary of the rationale behind those decisions is provided.

The Interim Report lists the 28 facilities by priority, in the same format used in the original Facilities Outlook. Some are noted individually; however others, for which the advice of Office of Science program advisory committees was insufficient to discriminate among relative priority, are listed in bands. In addition the facilities are grouped into near-term, mid-term, and far-term priorities over the full 20-year period, according to the anticipated R&D timeframe of the scientific opportunities they would address.

A central purpose of the 2003 Facilities Report, according to its introduction, was to offer a vision of the future and to reassure the public that it
'/>"/>

Contact: Jeff Sherwood
jeff.sherwood@hq.doe.gov
202-586-4826
DOE/US Department of Energy
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5

Related biology news :

1. PLoS Medicine publishes first trial of effect of male circumcision on HIV infection
2. DOE publishes research roadmap for developing cleaner fuels
3. Origen publishes in Nature a robust and versatile method for creating transgenic chickens
4. Marburg virus disease in Angola - update
5. Marburg haemorrhagic fever in Angola update
6. Updated data on novel HPV vaccine confirms efficacy in large population
7. MBL leads effort to update E. coli genome
8. Research updates 65-year-old genetic discovery
9. Mitochondrial DNA sequencing tool updated
10. Update on census of worlds most endangered cat -- Female Amur leopard found dead
11. HIV vaccine trial breaks ground for future research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... release is available in German . , Of all ...cumulate in the atmosphere where it contributes to...ceans and terrestrial ecosystems such as forests, ...service" of aquatic and terrestrial ecosystems is ...ways of reducing climate change. However, new gree...
(Date:11/22/2009)...sus of Marine Life scientists have inventoried an ...of deep sea species that have never known sunlight...gid black world down to 5,000 meters (~3 miles) be...cameras, sonar and other vanguard technologies, an...s now number 17,650, a diverse collection of speci...
(Date:11/22/2009)...bridge, MA November 23, 2009 Agios Pharmaceutica...ished, for the first time, that the mutated IDH1 g...cancer-causing gene, or oncogene. This breakthroug...oduces a metabolite, 2-hydroxyglutarate (2HG), whi...rogression of gliomas, the most common type of bra...
Breaking Biology News(10 mins):Intensive land management leaves Europe without carbon sinks 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4Gain Entry to the Closed 2009 Chicago Marathon by Joining Susan G Komens Marathon for the Cure 28R 29 48393 1Gain Entry to the Closed 2009 Chicago Marathon by Joining Susan G Komens Marathon for the Cure 28R 29 48393 2New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 1New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 2New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 3New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 4New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 5New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 6New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 7New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 8New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 9New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 10Landmark Study Published in New England Journal of Medicine 48389 1Landmark Study Published in New England Journal of Medicine 48389 2Landmark Study Published in New England Journal of Medicine 48389 3
...DA, Md. (July 1, 2008) Recipe to recover more quic...wash down with five or six cups of strong coffee. ...ng exercise, is replenished more rapidly when athl...ng exhaustive exercise, new research from the onli...shows. Athletes who ingested caffeine with carbohy...
...ogy of penguins makes these iconic swimming and di... susceptible to environmental changes. Pronounced ...shing, mining, and oil and gas development at lowe...according to P. Dee Boersma, of the University of ...ue of BioScience, Boersma provides a first-perso...
... July 1, 2008 The current standard practice of gi...event brain damage caused by oxygen deprivation ma... UT Southwestern Medical Center have found. , Bra...ypoxic-ischemic brain injury, is one of the most c...amage among infants and children. This can happen ...
Other Biology News:Post-exercise caffeine helps muscles refuel 2Post-exercise caffeine helps muscles refuel 3Post-exercise caffeine helps muscles refuel 4Resuscitation technique after brain injury may do more harm than good 2
(Date:11/23/2009)...Newswire/--ImmuneDesignC or p.(IDC)announcedtodayt...an.Dr.Carterhasasuccessfultrackrec or dinbiotechno...tiveOfficeratZymoGenetics,inSeattle,WAandChiefScie..., (Photo: http://www.newscom.com/cgi-bin/prnh/2...andChiefExecutiveOfficercommented,"Iamdelightedtow...
(Date:11/23/2009)...f.,Nov.23/PRNewswire/--Frost&Sullivan,theGrowt...emonstratingleadershipandinnovationThursday,Novemb...dsBanquetheldinSanAntonio,Texas. ,, (Logo: http...,, TheHealthcareInnovationAwardsaregiventocompa...eryandmanagementofhealthcare.Suchcompanieshaveshow...
(Date:11/23/2009)...PRNewswire-FirstCall/--CornerstoneTherapeuticsInc....usedonacquiring,developingandcommercializingsignif...arkets,todayannouncedthatCraigA.Collard,Presidenta...overviewatthe21stAnnualPiperJaffrayHealthCareConfe...orkPalaceHotelinNewYorkCity. ,, Aliveaudioandar...
(Date:11/20/2009)...n countries have an opportunity to take the lead i...m the University of Valencia (UV), working togethe...oductive fabric of the Spanish biotechnology indus...nt sectors have more clout than those in English-s... food and plants has been overlooked by the leadin...
Breaking Biology Technology:Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2
...ved for Marketing in the United States, Trade Name... TOKYO and INDIANAPOLIS, Jan. 4 Daiichi Sankyo,C...any (NYSE: LLY ) today,announced that on Wednesda...ation (NDA) for prasugrel to the U.S. Food and Dru...latelet agent, initially in development,for the tr...
... Calif., Jan. 4 Thermage, Inc.,(Nasdaq: THRM ), ...aesthetic,industry, announced today that it will p... Conference at The Palace Hotel in New York City. ..., January 11, 2008 at 11:00,a.m. Eastern Time. Ste...cutive Officer, will review the Company,s business...
...ORK (Oct. 31, 2007) -- In the face of terrorism an...trauma systems that improve survival for criticall...Yet many fundamental assumptions underlying these ...e to send the sickest patients to the hospital fir...tific scrutiny. Now, for the first time, researche...
Other Biology Technology:Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 2Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 3Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 4Triage study challenges notions of emergency medical response to disaster 2Triage study challenges notions of emergency medical response to disaster 3Triage study challenges notions of emergency medical response to disaster 4
...power supply are used for submerged horizontal gel... This Model 192 cell includes a buffer tank, a 25 ...uler, and a gel caster. The PowerPac basic power s...0-300 V, 4-400 mA, and 75 W. Power cord and instru...
...ages over traditional electrophoresis for DNA quan...nalysis, and size polymorphisms analysis. The eas...eal for basic research, method development, and qu...ry electrophoresis (CE) systems offer the ruggedne...
...ance of error. Thats the safeguard built into the ...ve experience in laboratory automation and leaders...EQ 8000 is a fully automated genetic analysis syst...array with a patented linear polyacrylamide (LPA) ...
Imaging Screen-K (Kodak), 35 x 43 cm from Bio-Rad
Biology Products: